cAMP levels were quantified in SSc MFs using the cAMP‐GLO assay after treating cells with a cAMP modulating agent in the presence of the non‐specific PDE inhibitor IBMX and PDE4 specific inhibitor Ro 20–1724 for 2 h. The gene discussed is ALDH7A1; the disease is systemic sclerosis.